A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma

Once-daily tiotropium Respimat 5 μg as add-on therapy to ICS with other maintenance therapy has been shown for the first time to provide improved lung function in children with severe symptomatic asthma.

http://ift.tt/2ku6Pcf